4 results about "PYY Peptide" patented technology

The present invention relates to peptides for use in the treatment of metabolic disorders. In particular, the present invention relates to peptides for use in the treatment of diabetes. According to the present invention, there is provided a peptide for use in the treatment of a metabolic disorder: wherein the peptide is a piscine-derived PYYor fragment or analogue thereof.

Provided are pharmaceutical compositions containing PYY (e.g., PYY(3-36) and its analogs and variants), sataiety peptides, sataiety hormones, metabolic hormones, and methods for treating metabolic disorders with such compositions. These embodiments include methods for enhancing well-being in patients treated with pharmaceutical compositions containing PYY, PYY(3-36), sataiety peptides, sataiety hormones, metabolic hormones, and analogs, receptor antagonists, and variants thereof.

The present invention relates to peptides for use in the treatment of metabolic disorders. In particular, the present invention relates to peptides for use in the treatment of diabetes. According to the present invention, there is provided a peptide for use in the treatment of a metabolic disorder; wherein the peptide is a piscine-derived PYY or fragment or analogue thereof.

The present invention relates to the pharmaceutical field, and specifically, to the following general formula (I): P-K-P-E-ψ-P-E-X 10 -D-X 12 -S-P-E-E-W-Q-R-Y-Y-X 22 -X 23 -L-R-H-Y-L-N-W-L-T-R-Q-R-Y-R1(I) A novel peptide tyrosine-tyrosine (PYY 3~36 ) analog or a salt or solvate thereof is provided, which contains the array structure as described above. The novel peptide YY analog (PYY 3~36 ) provided by the present invention has better pharmacological effects, longer action time, excellent bioavailability and safety.